Stocks to watch today : 23 June 2025

has received approval from Board of Directors for issuance of secured/ unsecured, redeemable, taxable/tax-free, cumulative/noncumulative, non-convertible debentures (Bonds/NCDs) up to Rs 18,000 crore in one or more tranches/series not exceeding 12, through private placement in domestic market during the period commencing from the date of passing of special resolution till completion of one year thereof, subject to approval of shareholders by the way of Postal Ballot. The size, tenure, listing details (BSE and/or NSE), coupon, security (if applicable) and other details as applicable will be decided at the time of issue of each tranche/series. ’ board has approved the acquisition of a majority stake in TISA Aerospace (TISA), an emerging defence technology company specializing in indigenously developed loitering munitions and unmanned aerial vehicles (UAVs). The acquisition will be executed through a combination of share purchase from existing shareholders of TISA and acquisition of compulsorily convertible debentures (CCDs) from existing holder issued by TISA. This investment represents a focused entry into the high-growth domain of loitering munitions and the ecosystem around it -- a rapidly evolving category of precision-guided weaponry that has demonstrated significant operational relevance in modern warfare. has secured additional orders worth Rs 585 crore. Major orders received include fire control and sighting system for missiles, communication equipment, jammers, spares, services etc. Emcure Pharmaceuticals has received approval for the acquisition of 4,095,180 equity shares, constituting 20.42% of the total issued and paid-up capital of Zuventus Healthcare (Zuventus), a subsidiary of the company, from all its individual shareholders, thereby making Zuventus a wholly-owned subsidiary of the company. The Board of Directors of the company at its meeting held on June 21, 2025, has approved the same.